Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants”
The purpose of this study is to evaluate the safety and tolerability of a single subcutaneous (SC) dose of JNJ-26366821.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - JNJ-26366821
Participants will receive sterile solution of JNJ-26366821 subcutaneously (SC).
Drug - Placebo
Participants will receive sodium chloride injection as placebo on Day 1.
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Volunteers
common.study.values.clinical-trial-id
NCT03990519
participant.views.study.view.id
b82r3e
